Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California 94303.
Neuroscience Department and Dorris Neuroscience Center, Scripps Research, La Jolla, California 92093.
J Neurosci. 2022 May 11;42(19):4042-4052. doi: 10.1523/JNEUROSCI.3100-20.2022. Epub 2022 Apr 8.
Retinal ganglion cells (RGCs) die after optic nerve trauma or in degenerative disease. However, acute changes in protein expression that may regulate RGC response to injury are not fully understood, and detailed methods to quantify new protein synthesis have not been tested. Here, we develop and apply a new quantitative measure of newly synthesized proteins to examine changes occurring in the retina after optic nerve injury. Azidohomoalanine, a noncanonical amino acid, was injected intravitreally into the eyes of rodents of either sex with or without optic nerve injury. Isotope variants of biotin-alkyne were used for quantitative BONCAT (QBONCAT) mass spectrometry, allowing identification of protein synthesis and transport rate changes in more than 1000 proteins at 1 or 5 d after optic nerve injury. screening showed several newly synthesized proteins regulate axon outgrowth in primary neurons This novel approach to targeted quantification of newly synthesized proteins after injury uncovers a dynamic translational response within broader proteostasis regulation and enhances our understanding of the cellular response to injury. Optic nerve injury results in death and degeneration of retinal ganglion cells and their axons. The specific cellular response to injury, including changes in new protein synthesis, is obscured by existing proteins and protein degradation. In this study, we introduce QBONCAT to isolate and quantify acute protein synthesis and subsequent transport between cellular compartments. We identify novel candidate protein effectors of the regenerative response and uncover their regulation of axon growth , validating the utility of QBONCAT for the discovery of novel regulatory and therapeutic candidates after optic nerve injury.
视网膜神经节细胞 (RGC) 在视神经损伤或退行性疾病后会死亡。然而,调控 RGC 对损伤反应的蛋白质表达的急性变化尚不完全清楚,也尚未测试详细的新蛋白质合成定量方法。在这里,我们开发并应用了一种新的定量测量新合成蛋白质的方法,以研究视神经损伤后视网膜中发生的变化。叠氮基同型亮氨酸是一种非典型氨基酸,被注入到雄性或雌性啮齿动物的眼内玻璃体中,无论是否有视神经损伤。生物素-炔烃的同位素变体用于定量 BONCAT(QBONCAT)质谱分析,允许在视神经损伤后 1 或 5 天检测超过 1000 种蛋白质的合成和转运率变化。筛选显示,几种新合成的蛋白质可调节原代神经元中的轴突生长。这种新的靶向定量损伤后新合成蛋白质的方法揭示了更广泛的蛋白质稳态调控中的动态翻译反应,并增强了我们对细胞对损伤反应的理解。视神经损伤导致视网膜神经节细胞及其轴突死亡和退化。现有的蛋白质和蛋白质降解掩盖了对损伤的特定细胞反应,包括新蛋白质合成的变化。在这项研究中,我们引入了 QBONCAT 来分离和定量急性蛋白质合成以及随后在细胞区室之间的运输。我们确定了新的候选再生反应效应蛋白,并揭示了它们对轴突生长的调节作用,验证了 QBONCAT 在视神经损伤后发现新的调节和治疗候选物的实用性。